Clinical trial
Exposure to Hazardous Substances and Associated Disability: A Nationwide Eight-Year Study, 2018-2025
NCT07879261 is registered in ClinicalTrials.gov with Sergio Gabriel Susmallian as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Exposure to Hazardous Substances and Associated Disability: A Nationwide Eight-Year Study, 2018-2025
- Lead sponsor
- Sergio Gabriel Susmallian
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2018
- Completion date
- December 31, 2025
- Enrollment
- 1,951 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
Arms
As registered; 1 arm.
-
Workers With Occupational Exposure to Hazardous Substances
Workers with occupational claims related to exposure to hazardous chemical substances and other non-solar hazardous agents recorded in the National Insurance Institute of Israel database between January 2018 and December 2025. The study includes administrative information on demographic characteristics, occupational exposure-related diagnoses, geographic distribution, medical assessments, temporary and permanent disability determinations, assigned disability severity, and compensation classifications. Solar and sunlight-related conditions are excluded from the diagnostic analysis. All data were collected retrospectively from existing administrative records.
Primary endpoints
Registered primary outcome measures; 1 primary.
-
Occupational Hazardous Substance-Exposure Claim Rate
Annual number of recognized occupational hazardous substance-exposure claims per 100,000 employed persons in Israel. Rates will be calculated using annual claim counts and the average national employed population. Temporal trends will be evaluated across the study period using regression models with appropriate denominator offsets. The outcome is an administrative claim rate rather than the incidence of occupational disease or exposure.
Lead sponsor's other trials
Sergio Gabriel Susmallian, most recent start first.
Similar trials
Same condition (Dermatitis, Contact) and phase, most recent start first.
+5 more trials See the condition page